Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Design, simulate, refine: simulation-guided clinical trials for accelerated drug development.

Nature reviews. Drug discovery·2026
Same author

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same author

Optimizing Clinical Study Report Development Through Lean Authoring: A Framework for Meeting Regulatory Expectations and Preparing for Automation.

Therapeutic innovation & regulatory science·2026
Same author

A Pilot Study to Explore Length and Readability Characteristics of Subject Information Sheets/Informed Consent Forms of Clinical Trial Applications in the EU.

Clinical and translational science·2026
Same author

When randomization is not random: Allocation bias in small sample, group sequential randomized clinical trials.

Statistical methods in medical research·2026
Same author

Local Immunometabolic Intervention With Alanyl-Glutamine Resolves Peritoneal Dialysis-Induced Immune Cell Dysfunction.

Kidney international reports·2026

相关实验视频

Updated: May 11, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K

开发通用模板来塑造未来进行综合研究平台试验的未来.

Madhavi Gidh-Jain1, Tom Parke2, Franz König3

  • 1, 55 Corporate Drive, Bridgewater, NJ, 08807, USA.

Trials
|March 22, 2024
PubMed
概括

新的模板简化了综合研究平台试验 (IRP),提高了同时进行多疗法评估的效果. 本指南支持适应性设计,提高临床试验效率和药物开发.

关键词:
欧盟以患者为中心的诊所Al tRial p平台综合研究平台试验 综合研究平台试验总协议模板 总协议模板

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
10:42

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Published on: June 17, 2022

2.9K

相关实验视频

Last Updated: May 11, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

10.6K
Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
10:42

Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics

Published on: June 17, 2022

2.9K

科学领域:

  • 临床试验 临床试验
  • 药物开发 药物开发
  • 监管科学 监管科学

背景情况:

  • 临床研究遵循国际协调理事会 (ICH) E6 (R2) 准则.
  • 综合研究平台 (IRP) 在同时进行多疗法评估方面越来越重要.
  • 现有的模板需要重新检查现代药物开发和监管挑战.

研究的目的:

  • 开发和传播一套模板,用于设计综合研究平台 (IRP).
  • 为适应性平台试验设计提供实际指导.
  • 支持复杂平台试验的设置,设计,规划,实施和进行.

主要方法:

  • 一项涉及监管医疗写作,生物统计和欧盟患者中心诊所Al tRial pPlatforms (EU-PEARL) 成员的合作努力.
  • 在3.5年的时间里,来自包括学术医院,制药公司,非政府组织,患者团体和中小企业在内的各种利益相关者的投入.
  • 基于TransCelerate的共同协议模板 (CPT) 和统计分析计划 (SAP) 的开发.

主要成果:

  • 一套IRP模板,包括TransCelerate CPT和EU-PEARL指南.
  • 模板为适应性设计提供实用建议,包括放弃无用的治疗或添加新的治疗.
  • 一个用户友好的平台试验最佳实践工具补充了模板,形成了一个全面的参考手册.

结论:

  • 欧盟-PEARL模板提高了IRP的设计和理解.
  • 参考用户手册和网站旨在促进创建IRP试验.
  • 传播这些资源将提高平台试验设计的效率和有效性.